The Value of Breast-Conserving Surgery Combined with Neoadjuvant Therapy for Breast Cancer

Objective: To observe the efficacy of different methods in the treatment of breast cancer disease. Methods: A sample of 78 patients attending the clinic from 2020.8 to 2023.1 was randomly selected and divided into groups A and B. Thirty-nine patients each underwent conventional breast-conserving surgery and group B combined with neoadjuvant therapy to compare the effectiveness of treatment between the groups. Results: The overall efficiency of group B vs group A was 94.87% vs 71.79%, a significant difference (P < 0.05). Surgery-related indicators were better in Group B than in Group A (P < 0.05). Conclusion: Early intervention with breast-conserving surgery combined with neoadjuvant therapy is recommended for patients with breast cancer and has demonstrated high clinical value